So far it seems promising, but the true impact of the FDA's newly unveiled 510(k) plan will lie in the details and how the changes are implanted. That is the conclusion many in the industry have come to in the wake of Wednesday's announcement by FDA. The agency had decided on 25 actions to move forward on this year in an effort to improve the controversial review process. (Medical Device Daily)
Read More
